Cargando…

Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer: results from the randomized SweBCG91RT trial

PURPOSE: Predictive biomarkers are needed to aid the individualization of radiotherapy (RT) in breast cancer. Cancer-associated fibroblasts have been implicated in tumor radioresistance and can be identified by platelet-derived growth factor receptor-beta (PDGFRb). This study aims to analyze how PDG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Strell, Carina, Stenmark Tullberg, Axel, Jetne Edelmann, Reidunn, Akslen, Lars Andreas, Malmström, Per, Fernö, Mårten, Holmberg, Erik, Östman, Arne, Karlsson, Per
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Preclinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062362/ https://www.ncbi.nlm.nih.gov/pubmed/33661437 http://dx.doi.org/10.1007/s10549-021-06136-4

Ejemplares similares

Expression of HGF, pMet, and pAkt is related to benefit of radiotherapy after breast‐conserving surgery: a long‐term follow‐up of the SweBCG91‐RT randomised trial
por: Sjöström, Martin, et al.
Publicado: (2020)

Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
por: Stenmark Tullberg, Axel, et al.
Publicado: (2023)

Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer: a long‐term follow‐up of the SweBCG91RT randomized trial
por: Egelberg, Moa, et al.
Publicado: (2023)

Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome
por: Mezheyeuski, Artur, et al.
Publicado: (2020)

Vessel size as a marker of survival in estrogen receptor positive breast cancer
por: Milosevic, Vladan, et al.
Publicado: (2023)

A PDGFRB- and CD40-targeting bispecific AffiMab induces stroma-targeted immune cell activation
por: Mega, Alessandro, et al.
Publicado: (2023)

The intra-tumoural stroma in patients with breast cancer increases with age
por: Vangangelt, Kiki M. H., et al.
Publicado: (2019)

Integrin α11β1 is expressed in breast cancer stroma and associates with aggressive tumor phenotypes
por: Smeland, Hilde Ytre‐Hauge, et al.
Publicado: (2019)

Prognostic value of tumor–stroma ratio combined with the immune status of tumors in invasive breast carcinoma
por: Vangangelt, K. M. H., et al.
Publicado: (2017)

Suppressive stroma-immune prognostic signature impedes immunotherapy in ovarian cancer and can be reversed by PDGFRB inhibitors
por: Yang, Dong, et al.
Publicado: (2023)

Development of the Swedish anticholinergic burden scale (Swe-ABS)
por: Rube, Tanja, et al.
Publicado: (2023)

Validation of the Swedish Trauma Registry (SweTrau)
por: Holmberg, Lina, et al.
Publicado: (2023)

Tumour cell expression of interleukin 6 receptor α is associated with response rates in patients treated with sunitinib for metastatic clear cell renal cell carcinoma
por: Pilskog, Martin, et al.
Publicado: (2018)

Poly-guanidine shows high cytotoxicity in glioma cell cultures and glioma stem cells
por: Márquez, Marcela, et al.
Publicado: (2022)

Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients
por: Engstrøm, M. J., et al.
Publicado: (2013)

The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast
por: Narbe, Ulrik, et al.
Publicado: (2019)

Association of reproductive history with breast tissue characteristics and receptor status in the normal breast
por: Gabrielson, Marike, et al.
Publicado: (2018)

Microglia Induce PDGFRB Expression in Glioma Cells to Enhance Their Migratory Capacity
por: Wallmann, Tatjana, et al.
Publicado: (2018)

Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trial
por: Stenmark Tullberg, Axel, et al.
Publicado: (2023)

Reliability of the DSS-Swe Questionnaire
por: Jans, Anders, et al.
Publicado: (2023)

Recurrent PDGFRB mutations in unicentric Castleman disease
por: Li, Zhaoming, et al.
Publicado: (2019)

Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC
por: Strell, Carina, et al.
Publicado: (2017)

Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up
por: Tutzauer, Julia, et al.
Publicado: (2022)

Evidence for PDGFRA, PDGFRB and KIT deregulation in an NSCLC patient
por: Negri, T, et al.
Publicado: (2007)

Genomic and clinical findings in myeloid neoplasms with PDGFRB rearrangement
por: Di Giacomo, Danika, et al.
Publicado: (2021)

Corneal Vascularization Associated With a Novel PDGFRB Variant
por: Gladkauskas, Titas, et al.
Publicado: (2023)

Fibroblasts—a key host cell type in tumor initiation, progression, and metastasis
por: Strell, Carina, et al.
Publicado: (2012)

Survival in endometrial cancer in relation to minimally invasive surgery or open surgery – a Swedish Gynecologic Cancer Group (SweGCG) study
por: Borgfeldt, Christer, et al.
Publicado: (2021)

Long‐term incidence of endometrial cancer after endometrial resection and ablation: A population based Swedish gynecologic cancer group (SweGCG) study
por: Flöter Rådestad, Angelique, et al.
Publicado: (2022)

Myeloid/Lymphoid Neoplasm with PDGFRB Rearrangement with t(5;10)(q33;q22) Harboring a Novel Breakpoint of the CCDC6-PDGFRB Fusion Gene
por: Yamazaki, Miki, et al.
Publicado: (2019)

Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS)
por: Wärnberg, Fredrik, et al.
Publicado: (2021)

SweC and SweD are essential co-factors of the FtsEX-CwlO cell wall hydrolase complex in Bacillus subtilis
por: Brunet, Yannick R., et al.
Publicado: (2019)

Novel PDGFRB rearrangement in multifocal infantile myofibromatosis is tumorigenic and sensitive to imatinib
por: Hassan, Mohammed, et al.
Publicado: (2019)

Protease Activated Receptors 1 and 2 Correlate Differently with Breast Cancer Aggressiveness Depending on Tumor ER Status
por: Lidfeldt, Jon, et al.
Publicado: (2015)

High CYP27A1 expression is a biomarker of favorable prognosis in premenopausal patients with estrogen receptor positive primary breast cancer
por: Inasu, Maria, et al.
Publicado: (2021)

Cdk1 and SUMO Regulate Swe1 Stability
por: Simpson-Lavy, Kobi J., et al.
Publicado: (2010)

Cohort profile: the Swedish Pancreatitis Cohort (SwePan)
por: Selin, Daniel, et al.
Publicado: (2022)

2D-SWE of the Metacarpophalangeal Joint Capsule in Horses
por: Guerri, Giulia, et al.
Publicado: (2022)

Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence after breast-conservation surgery, with or without postoperative radiotherapy
por: Niméus-Malmström, Emma, et al.
Publicado: (2008)

Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer
por: Sjöberg, Elin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qtk8u7rfu3ile7o9j27727aeoh